GE HealthCare Technologies Inc. - Common Stock (GEHC)

75.82
+4.71 (6.62%)
NASDAQ · Last Trade: Oct 29th, 12:54 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close71.11
Open76.00
Bid75.83
Ask76.47
Day's Range74.64 - 77.88
52 Week Range58.75 - 89.77
Volume9,569,679
Market Cap34.42B
PE Ratio (TTM)15.67
EPS (TTM)4.8
Dividend & Yield0.1600 (0.21%)
1 Month Average Volume3,738,910

Chart

About GE HealthCare Technologies Inc. - Common Stock (GEHC)

GE HealthCare Technologies Inc. is a leading global medical technology and digital solutions innovator focused on improving patient outcomes through advanced healthcare solutions. The company develops and manufactures a wide range of diagnostic imaging systems, monitoring devices, and healthcare IT services that empower healthcare providers to deliver accurate and efficient patient care. Through its commitment to innovation, GE HealthCare supports clinicians and patients by providing tools that enhance diagnostic capabilities, streamline workflows, and facilitate data-driven decision-making in an increasingly complex healthcare environment. Read More

News & Press Releases

GE HealthCare Technologies Q3 Earnings Call Highlightsmarketbeat.com
GE HealthCare Technologies (NASDAQ:GEHC) reported third-quarter 2026 revenue growth across all of its business segments, supported by demand in imaging and pharmaceutical diagnostics, improved execution in patient care products and margin expansion. Revenue totaled $5.5 billion, rising 6.2% organic
Via MarketBeat · October 28, 2026
S&P 500 Top Movers: Gainers and Losers in Today's US Sessionchartmill.com
Via Chartmill · October 28, 2026
GE HealthCare (GEHC) Q3 2026 Earnings Call Transcriptfool.com
Backlog surged 12% to $23.7 billion on imaging and diagnostics demand.
Via The Motley Fool · October 28, 2026
GE HealthCare (NASDAQ:GEHC) Q3 Earnings Beat and Raised Guidance Drive Premarket Gainschartmill.com
Via Chartmill · October 28, 2026
S&P 500 Top Movers: October 28 Gainers and Loserschartmill.com
Via Chartmill · October 28, 2026
GE HealthCare (GEHC) stock trades up, here is why
What happened? Shares of healthcare technology company GE HealthCare Technologies (NASDAQ:GEHC) jumped 7.2% in the morning session after the company delivere...
Via StockStory · October 28, 2026
S&P 500 Gap Movers: Oct. 28 Sessionchartmill.com
Via Chartmill · October 28, 2026
S&P 500 Premarket Movers for Oct. 28, 2026chartmill.com
Via Chartmill · October 28, 2026
GE HealthCare’s (NASDAQ:GEHC) Q3 2026 sales beat estimates
Healthcare technology company GE HealthCare Technologies (NASDAQ:GEHC) reported Q3 2026 results exceeding the market’s revenue expectations, with revenue up ...
Via StockStory · October 28, 2026
GE HealthCare reports third quarter 2026 financial results
GE HealthCare (Nasdaq: GEHC) today reported financial results for the third quarter ended September 30, 2026.
By GE HealthCare · Via Business Wire · October 28, 2026
GE HealthCare (GEHC) reports earnings tomorrow: what to expect
Healthcare technology company GE HealthCare Technologies (NASDAQ:GEHC) will be announcing earnings results this Wednesday before the bell. Here’s what to loo...
Via StockStory · October 26, 2026
1 cash-producing stock worth investigating and 2 we turn down
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient...
Via StockStory · October 23, 2026
GE HealthCare announces five new global collaborations to advance the next generation of theranostics imaging
GE HealthCare (Nasdaq: GEHC) today announced a global clinical evaluation program spanning three continents and five internationally recognized institutions to assess StarGuide™ GX,i its next-generation digital 4D SPECT/CT system. Participating institutions include Hadassah Medical Center in Israel; Mayo Clinic in the United States; Oncopole Claudius Regaud – Institut Universitaire du Cancer de Toulouse in France; Peking University First Hospital in China; and Rambam Health Care Campus.
By GE HealthCare · Via Business Wire · October 20, 2026
GE HealthCare expands general imaging ultrasound portfolio with LOGIQ Focus, elevating everyday ultrasound performance
GE HealthCare today announced LOGIQ™ Focus, a new addition to its LOGIQ family of general imaging ultrasound systems, designed to bring advanced imaging tools to a broader range of ultrasound exams. LOGIQ Focus is a versatile ultrasound system that pairs high-quality LOGIQ imaging with AI-enabled, automation and productivity tools intended to support greater confidence, consistency and efficiency across routine and more complex care areas.
By GE HealthCare · Via Business Wire · October 19, 2026
3 Stocks Delivering Bigger Dividends Despite Market Uncertaintymarketbeat.com
T-Mobile, GE HealthCare, and Danaos all recently raised dividends with low payout ratios, including T-Mobile's near-15% hike after SpaceX's spectrum deal hit its stock.
Via MarketBeat · October 17, 2026
Research conducted at University of Michigan published in Anesthesia & Analgesia Practice demonstrates GE HealthCare End-tidal Control software may help to reduce fresh gas flow
GE HealthCare (Nasdaq: GEHC) today announced the publication of research conducted at the University of Michiganiv evaluating the use of End-tidal Control software across a large multisite academic health system in Anesthesia & Analgesia Practice. The retrospective observational study analyzed 12,818 adult general anesthesia cases performed at University of Michigan Health – Ann Arbor locations between April 1, 2023 and September 30, 2024 on anesthesia machines with End-tidal Control software.
By GE HealthCare · Via Business Wire · October 16, 2026
GE HealthCare's MINItrace™ Magni achieves CE Mark; Copper-64 expands PETtrace™ Solid Target Platform beyond Gallium-68
GE HealthCare (Nasdaq: GEHC) today announced that its MINItrace Magni cyclotron has achieved CE Mark and that its PETtrace Solid Target Platform is expanding beyond Gallium-68 with support for Copper-64 (⁶⁴Cu) production. Together, the developments reflect the company’s focus on helping institutions build the production capabilities behind their molecular imaging programs—from establishing local PET radioisotope production to supporting research into emerging radiopharmaceuticals.
By GE HealthCare · Via Business Wire · October 15, 2026
2 Beaten-Down Healthcare Stocks That Could Soar in the Fourth Quarterfool.com
Both stocks are in negative territory this year, but upcoming earnings reports could change how investors view their prospects.
Via The Motley Fool · October 14, 2026
GE HealthCare (GEHC): Buy, Sell, or Hold Post Q2 Earnings?
Over the last six months, GE HealthCare’s shares have sunk to $68.00, producing a disappointing 7.9% loss - a stark contrast to the S&P 500’s 13.5% gain. Thi...
Via StockStory · October 13, 2026
Discover which S&P500 stocks are making waves on Monday.chartmill.com
Via Chartmill · October 12, 2026
2 Nasdaq 100 Stocks to Own for Decades and 1 We Question
The Nasdaq 100 (^NDX) is home to some of the biggest success stories in tech and growth investing. However, certain stocks in the index face challenges like ...
Via StockStory · October 9, 2026
2 Mid-Cap Stocks to Keep an Eye On and 1 We Question
Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the man...
Via StockStory · October 8, 2026
GE HealthCare to announce third quarter 2026 results on October 28, 2026
GE HealthCare (Nasdaq: GEHC) will announce its third quarter 2026 financial results before the market opens on Wednesday, October 28, 2026. The GE HealthCare management team will also host a conference call and webcast at 8:30 a.m. Eastern Time / 7:30 a.m. Central Time on that same day, which will be a live webcast and accessible at https://investor.gehealthcare.com/news-events/events. The earnings release, accompanying financial information, and webcast replay also will be posted at the same link on the GE HealthCare Investor Relations website.
By GE HealthCare · Via Business Wire · October 7, 2026
GE HealthCare to Acquire SOFIE Biosciences, Establishing a 'Final Mile' Footprint for PET Radiopharmaceutical Supply in the U.S.
GE HealthCare (Nasdaq: GEHC) today announced a definitive agreement to acquire SOFIE Biosciences, a leading U.S.-based CMO for PET radiopharmaceuticals, from Trilantic North America, for a purchase price of $945 million paid in cash. The transaction is expected to close in the first half of 2027, subject to closing conditions, including regulatory approvals, at which time SOFIE Biosciences will become part of GE HealthCare’s PDx segment.
By GE HealthCare · Via Business Wire · October 5, 2026
Healthcare Equipment and Supplies Stocks Q2 Highlights: GE HealthCare (NASDAQ:GEHC)
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at ...
Via StockStory · September 27, 2026